Our research at the Wellcome Trust Sanger Institute builds understanding of gene function in health and disease as well as creating resources of lasting value to biomedical research. . . We study diseases that have an impact on health globally by investigating genomes. Building on our past achievements and based on priorities that exploit the unique expertise of our Faculty of researchers, we will lead global efforts to understand the biology of genomes. We are convinced of the importance of making this research available and accessible for all audiences.
WuXi AppTec is a leading open-access R&D capability and technology platform with operations in China, USA, Germany and Iceland. As an innovation-driven and customer-focused company, WuXi AppTec provides a broad and integrated portfolio of services to help our partners shorten the discovery and development time and lower the cost of drug and medical device R&D through cost-effective and efficient solutions. With its industry-leading capabilities in small molecule, biologics, cell therapy and gene therapy, medical device testing, and molecular testing and genomics, WuXi is enabling more than 2000 collaborators from more than 30 countries to bring innovative healthcare products to patients.